Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Enanta Pharmaceuticals Inc. buy Robert W. Baird

Start price
€7.70
26.11.24 / 50%
Target price
€19.09
26.11.25
Performance (%)
53.25%
End price
€11.80
27.11.25
Summary
This prediction ended on 27.11.25 with a price of €11.80. The BUY prediction by Robert_W__Baird for Enanta Pharmaceuticals Inc. saw massive gains of 53.25%. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Enanta Pharmaceuticals Inc. 0.000% 0.000% 115.789%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Robert_W__Baird for this prediction

In the thread Enanta Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 53.25%
Target price 19.094
Change
Ends at 26.11.25

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at Robert W. Baird from $26.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for ENTA provided by MarketBeat

In the thread Trading Enanta Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 53.25%
Target price 19.094
Change
Ends at 26.11.25

Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten